DNAe, the Next-Generation Sequencing (NGS) company developing a transformative fully automated, sample-to-report diagnostics platform, today unveils a new Early Access Program, offering clinical ...

Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

Automated library preparation is critical for reducing errors, increasing repeatability, and reducing hands-on time, allowing researchers to generate sequence data from DNA more quickly. The CyBio ...

Please provide your email address to receive an email when new articles are posted on . Next-generation sequencing testing rates have increased for patients with metastatic prostate or urothelial ...

Next-generation sequencing uses massive parallelism to sequence millions, if not billions, of DNA strands. This method is also known as high throughput sequencing. Compared to NGS, Sanger genome ...

The next generation sequencing market offers significant opportunities by enhancing the diagnosis and treatment of chronic ...

Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...

In a new trial, patients with B-acute lymphoblastic leukemia (B-ALL) who had no evidence of remaining cancer cells after ...

Among pediatric and young adult patients with B-cell acute lymphoblastic leukemia (ALL), the removal of total body irradiation (TBI) from conditioning did not compromise efficacy, and was comparable ...

DNAe, the Next-Generation Sequencing (NGS) company developing a transformative fully automated, sample-to-report diagnostics platform, today unveils a new Early Access Program, offering clinical partn ...